This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stevenson, L. W. Articles by Alt, E. U. Search for Related Content PubMed PubMed Citation Articles by Stevenson, L. W. Articles by Alt, E. U. Pubmed/NCBI databases Medline Plus Health Information Heart Failure Related Collections Other heart failure

(Circulation. 2006;113:1020-1033.)
© 2006 American Heart Association, Inc.

Controversies in Cardiovascular Medicine

Are hemodynamic goals viable in tailoring heart failure therapy?

Hemodynamic Goals Are Relevant

Lynne Warner Stevenson, MD

From Brigham and Women’s Hospital Cardiovascular Division, Advanced Heart Disease Section, Boston, Mass (L.W.S.); the Heart Failure and Transplant Program, Department of Medicine, Section of Cardiology, Tulane University School of Medicine (T.H.L.J.); Cardiovascular Research, Department of Medicine, Section of Cardiology, Tulane University School of Medicine; and Department of Biomedical Engineering, Tulane University School of Engineering (E.U.A.), New Orleans, La.

Correspondence to Lynne Warner Stevenson, MD, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115; or Thierry H. Le Jemtel, MD, Tulane University School of Medicine, 1430 Tulane Ave, SL 48, New Orleans, LA 70112 (e-mail lejemtel@tulane.edu).

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
The diversity of patient profiles and responses precludes a one-size-fits-all approach to heart failure. The randomized trials have provided us with some therapies that must be tried and others that can be tried. Offering significant although small benefits averaged over a population, these therapies are bolts of fabric stacked beside a tailor’s mannequin, the typical trial subject. The sequential patching of different medications in the order of their investigation, however, is not likely to yield the best regimen for any patient. There should be little disagreement on the principle of tailoring therapies for individuals, but what measurements should be taken?

	Tailored to What?

 
The primary goal for asymptomatic and mildly symptomatic heart failure is to prevent or delay disease progression. Once symptoms and the risk of mortality dominate, the goals are to relieve symptoms and prolong survival. It has been proposed that hemodynamic goals are not appropriate in the care of these patients with heart failure. To construct the clearest case to the contrary, this discussion will focus on patients with advanced heart failure as those in whom hemodynamic abnormalities are most apparent (although a case can also be made for contributions of early rises in intracardiac pressures, blunting of natriuretic peptide responses, fluid retention, and valvular regurgitation and disease progression). Advanced heart failure will be defined here in those patients with dilated ventricles and low ejection fraction who have persistent or recurrent symptoms limiting daily life (New York Heart Association class III and IV)¹ despite initiation of angiotensin-converting enzyme inhibitors, ß-blockers, and . . . [Full Text of this Article]

Thierry H. Le Jemtel, MD; Eckhard U. Alt, MD

Lynne Warner Stevenson, MD

Thierry H. Le Jemtel, MD; Eckhard U. Alt, MD

This article has been cited by other articles:

				P. C. Colombo, D. Onat, and H. N. Sabbah Acute heart failure as "acute endothelitis" -- Interaction of fluid overload and endothelial dysfunction Eur J Heart Fail, February 1, 2008; 10(2): 170 - 175. [Full Text] [PDF]

				H. E. Verdejo, P. F. Castro, R. Concepcion, M. A. Ferrada, M. A. Alfaro, M. E. Alcaino, C. C. Deck, and R. C. Bourge Comparison of a Radiofrequency-Based Wireless Pressure Sensor to Swan-Ganz Catheter and Echocardiography for Ambulatory Assessment of Pulmonary Artery Pressure in Heart Failure J. Am. Coll. Cardiol., December 18, 2007; 50(25): 2375 - 2382. [Abstract] [Full Text] [PDF]

				K. Damman, G. Navis, T. D.J. Smilde, A. A. Voors, W. van der Bij, D. J. van Veldhuisen, and H. L. Hillege Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction Eur J Heart Fail, September 1, 2007; 9(9): 872 - 878. [Abstract] [Full Text] [PDF]